 Globe and Mail |
Gilead to acquire Pharmasset for nearly $11bln
MarketWatch Barclays Capital and Bank of America Merrill Lynch are acting as financial advisors to Gilead in the transaction. Morgan Stanley & Co. LLC is acting as the financial advisor to Pharmasset. Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal … Greenberg Traurig Represents Morgan Stanley as Financial Advisor to Pharmasset … Gilead's $11B Pharmasset Buy Validates Nuc Prodrug Strategy |
Gilead to acquire Pharmasset for nearly $11bln – MarketWatch
Gilead to acquire Pharmasset for nearly $11bln – MarketWatch
Globe and Mail |
Gilead to acquire Pharmasset for nearly $11bln
MarketWatch Barclays Capital and Bank of America Merrill Lynch are acting as financial advisors to Gilead in the transaction. Morgan Stanley & Co. LLC is acting as the financial advisor to Pharmasset. Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal … Greenberg Traurig Represents Morgan Stanley as Financial Advisor to Pharmasset … Gilead's $11B Pharmasset Buy Validates Nuc Prodrug Strategy |
